We are pleased to announce that Professor Camilla Hrdy will serve as a co-director of the Rutgers Institute for Information Policy & Law (RIIPL), along with co-directors Ellen P. Goodman and Michael Carrier. Professor Hrdy joined Rutgers Law School as an Associate Professor in 2024 and is an Affiliated Fellow at the Yale Law School … Continue reading New RIIPL Co-Director, Prof. Camilla Hrdy…
Category: News
The “Defend Trade Secrets Act At Ten” Conference Makes A Splash
Last Friday, several esteemed trade secret scholars had a blast at the “The Defend Trade Secrets Act at 10” Conference in Columbia, Missouri. The weather cooperated, with attendees enjoying sunshine and a steady temp of around 73 degrees. In his characteristically insightful opening comments, Ryan Vacca (University of Missouri) concisely identified the conference’s topic as: … Continue reading The “Defend Trade Secrets Act At Ten” Conference Makes A Splash…
Prof. Carrier publishes 2 articles, a book chapter, and a policy piece
Prof. Carrier published: FTC v. Qualcomm: The Difficult Path for Antitrust FRAND Challenges in the U.S., FRAND Cases in Context (Jorge Contreras editor, Edward Elgar); Competitive Concerns from Pharmacy Benefit Managers Selling Their Own Drugs (with Rachel Sachs), in the Yale Journal of Health Policy, Law, and Ethics; Seven Types of Standard Essential Patents Abuse … Continue reading Prof. Carrier publishes 2 articles, a book chapter, and a policy piece…
Prof. Carrier gives 5 talks
Prof. Carrier presented “PBMs: The Hidden Actor Behind Product Hopping” at (1) the Health, Innovation, and the Law Colloquium at the University of Texas Law School; (2) a Temple Law School class on Current Topics in Antitrust Law; and (3) (by Zoom) the Cambridge-USC Antitrust Workshop. He also presented “Settlements and Value” at the Saint … Continue reading Prof. Carrier gives 5 talks…
Prof. Carrier co-authors Supreme Court brief
With Charles Duan, Sean Tu, and Aaron Kesselheim, Prof. Carrier filed a Brief of 76 Scholars of Law, Business, Economics, and Medicine as Amici Curiae in Support of Petitioners in the case Hikma Pharmaceuticals v. Amarin Pharma, Inc. et al. in the Supreme Court. Read the brief here.